Prof. Dr. Asmus Finzen ein Beitrag in der WELT Rubrik: "Das Alter"
predemtec_WELT_DasAlter.pdf (411,8 KiB)
Alzheimer’s drug-development pipeline: 2016
Alzheimer¹s drug-development pipeline- 2016.pdf (876,8 KiB)
Prof. Asmus Finzen Früh- und Risikodiagnostik bei Demenz – warum, wie?
Früh- und Risikodiagnostik bei Demenz – warum, wie?.pdf (37,8 KiB)
Alzheimer: Tau-Forscher wittern Morgenluft
Alzheimer’s Disease Biomarkers – Are In-vitro Diagnostics Really Needed?
Alzheimer’s dementia begins as a disease of small blood vessels, damaged by oxidative- induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy
A Meta-Analysis of Cytokines in Alzheimer’s Disease
